Skip to main content

Table 1 Patient characteristics at baseline (n = 40)

From: Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer

Patient characteristics Value
Median (range) age, years 63 (54–66)
Gender, n (%)  
 Male 30 (75.0)
 Female 10 (25.0)
ECOG PS, n (%)  
 0 20 (50.0
 1 20 (50.0)
TNM status, n (%)
 T3* 32 (80.0)
 T3a 3 (7.5)
 T3b 1 (2.5)
 T3c 2 (5.0)
 T4 2 (5.0)
 Nx 1 (2.5)
 N0 1 (2.5)
 N1 24 (60.0)
 N2 14 (35.0)
  1. *It was not specified if the T3 status was T3a, T3b or T3c.